Remove Dermatology Remove Filler Remove Marketing
article thumbnail

Medical Aesthetics: “Redefining Beauty through Medical Expertise”

Roots Analysis

Afterwards, in 2003, the FDA approved Hyaluronic Acid Fillers (HA dermal fillers), bringing the much-anticipated innovation to all types of face and non-face augmentation products. Moreover, at present, women dominate the medical aesthetics industry with over 90% market share.

Filler 40
article thumbnail

Crescita Announces Licensing Agreement for Pliaglis; in China

The Pharma Data

TSX: CTX) (OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house research & development (“R&D”) and manufacturing capabilities, today announced that it has entered into an exclusive agreement with Juyou-Biotechnology Co.